The Association of Pre-Kidney Transplant Dialysis Modality with de novo Posttransplant Heart Failure.
Cohort study
End-stage renal disease
Heart failure
Hemodialysis
Kidney transplantation
Outcomes
Peritoneal dialysis
US Renal Data System
Journal
Cardiorenal medicine
ISSN: 1664-5502
Titre abrégé: Cardiorenal Med
Pays: Switzerland
ID NLM: 101554863
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
02
2021
accepted:
25
06
2021
pubmed:
14
9
2021
medline:
1
1
2022
entrez:
13
9
2021
Statut:
ppublish
Résumé
Heart failure (HF) after kidney transplantation is a significant but understudied problem. Pretransplant dialysis modality could influence incident HF risk through differing cardiac stressors. However, whether pretransplant dialysis modality is associated with the development of posttransplant HF is unknown. We used the US Renal Data System to assemble a cohort of 27,701 patients who underwent their first kidney transplant in the USA between the years 2005 and 2012 and who had Medicare fee-for-service coverage for >6 months preceding their transplant date. Patients with any HF diagnosis prior to transplant were excluded. Detailed baseline patient characteristics and comorbidities were abstracted. The outcome of interest was de novo posttransplant HF. Pretransplant dialysis modality was defined as the dialysis modality used at the time of transplant. We conducted time-to-event analyses using Cox regression. Death was treated as a competing risk in the study's primary analysis. Graft failure was included as a time-varying covariate. Among eligible patients, 81% were treated with hemodialysis prior to transplant, and hemodialysis patients were more likely to be male, had a shorter dialysis vintage, and had more diabetes and vascular disease diagnoses. When adjusted for all available demographic and clinical data, pretransplant treatment with hemodialysis (vs. peritoneal dialysis) was associated with a 19% increased risk in de novo posttransplant HF, with sub-distribution HR 1.19 (95% CI: 1.09-1.29). Our results suggest that choice of pretransplant dialysis modality may impact the development of posttransplant HF.
Sections du résumé
BACKGROUND
Heart failure (HF) after kidney transplantation is a significant but understudied problem. Pretransplant dialysis modality could influence incident HF risk through differing cardiac stressors. However, whether pretransplant dialysis modality is associated with the development of posttransplant HF is unknown.
METHODS
We used the US Renal Data System to assemble a cohort of 27,701 patients who underwent their first kidney transplant in the USA between the years 2005 and 2012 and who had Medicare fee-for-service coverage for >6 months preceding their transplant date. Patients with any HF diagnosis prior to transplant were excluded. Detailed baseline patient characteristics and comorbidities were abstracted. The outcome of interest was de novo posttransplant HF. Pretransplant dialysis modality was defined as the dialysis modality used at the time of transplant. We conducted time-to-event analyses using Cox regression. Death was treated as a competing risk in the study's primary analysis. Graft failure was included as a time-varying covariate.
RESULTS
Among eligible patients, 81% were treated with hemodialysis prior to transplant, and hemodialysis patients were more likely to be male, had a shorter dialysis vintage, and had more diabetes and vascular disease diagnoses. When adjusted for all available demographic and clinical data, pretransplant treatment with hemodialysis (vs. peritoneal dialysis) was associated with a 19% increased risk in de novo posttransplant HF, with sub-distribution HR 1.19 (95% CI: 1.09-1.29).
CONCLUSIONS
Our results suggest that choice of pretransplant dialysis modality may impact the development of posttransplant HF.
Identifiants
pubmed: 34515084
pii: 000518535
doi: 10.1159/000518535
pmc: PMC8678165
mid: NIHMS1726214
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
209-217Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK095024
Pays : United States
Informations de copyright
© 2021 The Author(s) Published by S. Karger AG, Basel.
Références
PLoS One. 2015 Apr 24;10(4):e0124772
pubmed: 25909952
Am J Kidney Dis. 2014 Mar;63(3):491-9
pubmed: 24210591
Curr Opin Nephrol Hypertens. 2010 Nov;19(6):592-7
pubmed: 20827196
Cardiology. 1999;92(4):236-9
pubmed: 10844383
Stat Med. 2008 Nov 29;27(27):5709-24
pubmed: 18712779
Kidney Int. 1996 Jul;50(1):235-42
pubmed: 8807593
N Engl J Med. 1999 Dec 2;341(23):1725-30
pubmed: 10580071
Nephrol Dial Transplant. 2002 Sep;17(9):1661-6
pubmed: 12198220
Nephrol Dial Transplant. 2006 Feb;21(2):254-7
pubmed: 16293634
Pediatr Nephrol. 2015 Jun;30(6):999-1005
pubmed: 25395362
Hemodial Int. 2013 Oct;17 Suppl 1:S17-21
pubmed: 24134325
Ren Fail. 2008;30(4):391-400
pubmed: 18569912
J Clin Invest. 2011 Nov;121(11):4393-408
pubmed: 21985788
Clin J Am Soc Nephrol. 2009 Sep;4(9):1477-1483
pubmed: 19713289
Am J Transplant. 2004 Dec;4(12):2038-44
pubmed: 15575907
Clin J Am Soc Nephrol. 2009 May;4(5):914-20
pubmed: 19357245
Kidney Int. 2003 Sep;64(3):1071-9
pubmed: 12911559
Cardiorenal Med. 2015 Feb;5(1):20-30
pubmed: 25759697
J Am Soc Nephrol. 2005 Sep;16(9):2778-88
pubmed: 16033855
Perit Dial Int. 2001 Jan-Feb;21(1):36-42
pubmed: 11280494
Am J Kidney Dis. 1999 Jul;34(1):125-34
pubmed: 10401026
Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7
pubmed: 24360288
Am J Kidney Dis. 2005 Oct;46(4):720-33
pubmed: 16183428
J Am Soc Nephrol. 1995 Jun;5(12):2024-31
pubmed: 7579050
Circ Cardiovasc Imaging. 2012 Mar;5(2):251-61
pubmed: 22360996
PLoS One. 2013 May 13;8(5):e62722
pubmed: 23675418
Circulation. 2019 Jun 18;139(25):2809-2818
pubmed: 31045455
Am J Kidney Dis. 2010 Apr;55(4):682-9
pubmed: 20089339
N Engl J Med. 2001 Mar 8;344(10):726-31
pubmed: 11236776